This review aims to evaluate the existing evidence on the prognostic role of obesity in BC patients and assess current data regarding the efficacy and safety of GLP-1 receptor agonists (GLP-1 RAs) in women with overweight or obesity with BC. Here, GLP1R is linked to breast cancer.